LEADER 00999nam a2200241 i 4500 001 991003204909707536 005 20021205143752.0 008 021017s|||| us ||| | ||| 020 $a0231024444 035 $ab11770624-39ule_inst 035 $aPARLA221861$9ExL 040 $aDip.to Scienze Storiche Filosofiche e Geografiche$bita 100 0 $aHugo :$cde Sancto Victore$0195330 245 14$aThe Didascalicon of Hugh of St. Victor :$ba medieval guide to the arts /$ctranslated from the latin with an introduction and notes by Jerome Taylor 260 $aNew York ; London :$bColumbia University press,$c1961 300 $a254 p. ;$c24 cm. 700 1 $aTaylor, Jerome 907 $a.b11770624$b21-09-06$c09-12-02 912 $a991003204909707536 945 $aLE009 STOR.35-179$g1$i2009000132658$lle009$o-$pE0.00$q-$rn$so $t0$u0$v0$w0$x0$y.i12016846$z09-12-02 996 $aDidascalicon of Hugh of St. Victor$9907008 997 $aUNISALENTO 998 $ale009$b01-01-02$cm$da $e-$feng$gus $h4$i1 LEADER 02948nam 2200409 450 001 9910583021803321 005 20230120002734.0 010 $a0-323-55430-X 035 $a(CKB)4100000004831985 035 $a(MiAaPQ)EBC5419709 035 $a(EXLCZ)994100000004831985 100 $a20180628d2019 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aStroke prevention in atrial fibrillation /$fGreg Flaker 210 1$aSt. Louis, Missouri :$cElsevier,$d[2019] 210 4$dİ2019 215 $a1 online resource (203 pages) $cillustrations 311 $a0-323-55429-6 320 $aIncludes bibliographical references and index. 327 $a1. An Economic Analysis of Stroke and Atrial Fibrillation / Arnold J. Greenspon, MD -- 2. Pharmacology of Oral Anticoagulants / Paul P. Dobesh, PharmD, FCCP, BCPS and Zachary A. Stacy, PharmD, FCCP, BCPS -- 3. Anticoagulation Drug Trials for Stroke Prevention in Atrial Fibrillation / David A. Manly, MD and Christopher B. Granger, MD -- 4. Risk Stratification in Atrial Fibrillation / Farhan Shahid, MBBS, BSc, Mikhail Dzeshka, MD, Eduard Shantsila, MD, PhD and Gregory Y.H. Lip, MD, FRCP, FACC, FESC -- 5. Subclinical Atrial Fibrillation: Definition, Prevalence, and Treatment Strategies / Abhinav Sharma, MD, FRCPC and Renato D. Lopes, MD, MHS, PhD -- 6. The New Anticoagulation Clinic / Anne E. Rose, PharmD -- 7. Management of Bleeding Associated With Anticoagulation / Geno J. Merli, MD, MACP, FSVM, FHM and Lynda Thomson, PharmD -- 8. Periprocedural Management of Anticoagulation in Patients With Atrial Fibrillation / Richard Weachter, MD and Greg Flaker, MD -- 9. Special Situations: Anticoagulation for Cardioversion / Chad Ward, MD and Michael C. Giudici, MD, FACC, FACP, FHRS -- 10. Anticoagulation for Ablation Procedures / Michael C. Giudici, MD, FACC, FACP, FHRS and Bria Giacomino, DO -- 11. Surgical and Implanted Devices for the Left Atrial Appendage / Sandeep Gautam, MD, MPH and Joshua Payne, MD, MPH -- 12. Patients Taking Oral Anticoagulants for Atrial Fibrillation With Concomitant Complex Disease States / William J. Hucker, MD, PhD, Mitul Kanzaria, MD, and John U. Doherty, MD, FACC -- 13. Stroke and Atrial Fibrillation: The Neurologist's Perspective / Luciana Catanese, MD and Robert G. Hart, MD -- 14. Stroke and Atrial Fibrillation in Chronic Kidney Disease and Dialysis / David Collister, MD and Michael Walsh, MD, PhD. 606 $aCerebrovascular disease$xPrevention 606 $aAtrial fibrillation 615 0$aCerebrovascular disease$xPrevention. 615 0$aAtrial fibrillation. 676 $a616.8106 700 $aFlaker$b Greg$0866185 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910583021803321 996 $aStroke prevention in atrial fibrillation$91933231 997 $aUNINA